News
US antivirals major Gilead Sciences (Nasdaq: GILD) yesterday released positive top-line results from the Phase III ASCENT-03 ...
Norwegian cancer drug developer Clavis Pharma (OSE: CLAVIS) develops and commercializes improved cancer drugs based on its proprietary technologies. Norwegian cancer drug developer Clavis Pharma (OSE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback